Meet the Start-ups

Marijn van Os | CEO | Scinvivo

Marijn van Os is CEO at Scinvivo, since October 2019 and co-founded of Scinvivo in 2016. As an entrepreneur he also founded Innoluce in 2010 as a spin-off of Royal Philips, including acquiring the main MEMS mirror IPR. Marijn successfully managed the acquisition of Innoluce by Infineon in 2016 for the automotive applications. Prior to this acquisition the medical assets, IPR and knowhow was transferred to Scinvivo. Marijn holds a PhD in mechanical engineering and continued his working career at Philips where he held different positions as technologist and development manager within The Netherlands and in the Czech Republic. Marijn has an extensive international network in the MEMS space and in the medical space for Urology.

Marijn is always looking for opportunities to improve and challenge the status quo and as such he is convinced that with the solution of Scinvivo the unmet needs in the cancer diagnostics & care will be improved significantly for all stakeholders, but in particular for the patients.

Scinvivo

Scinvivo first focusses on the medical needs in bladder cancer. Scinvivo’s forward-looking OCT-catheter provides the answer by giving urologists real time ultra high resolution (a few micrometers) insight in the anatomical structure during diagnosis (cystoscopy).

During cystoscopy, only the surface of the bladder wall is visible. Getting insight into the anatomical structure is crucial for a fast and better diagnosis.

Using Scinvivo's OCT catheter addresses directly the unmet needs in bladder cancer diagnosis & care:

1. differentiating between non-invasive (TIS - T1) and muscle-invasive bladder cancer(T2 - T4) as early as possible in the diagnostic process (a faster diagnosis increases the survival chances up to 30%),

2. the follow-up monitoring of BC patients to reduce the number of unnecessary surgeries caused by false positives (up to 50% of the surgeries).